Literature DB >> 17483096

Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances.

Neil Ashley1, Susan Adams, Abdelhamid Slama, Massimo Zeviani, Anu Suomalainen, Antonio L Andreu, Robert K Naviaux, Joanna Poulton.   

Abstract

Defects in mtDNA maintenance range from fatal multisystem childhood diseases, such as Alpers syndrome, to milder diseases in adults, including mtDNA depletion syndromes (MDS) and familial progressive external ophthalmoplegia (AdPEO). Most are associated with defects in genes involved in mitochondrial deoxynucleotide metabolism or utilization, such as mutations in thymidine kinase 2 (TK2) as well as the mtDNA replicative helicase, Twinkle and gamma polymerase (POLG). We have developed an in vitro system to measure incorporation of radiolabelled dNTPs into mitochondria of saponin permeabilized cells. We used this to compare the rates of mtDNA synthesis in cells from 12 patients with diseases of mtDNA maintenance. We observed reduced incorporation of exogenous alpha (32)P-dTTP in fibroblasts from a patient with Alpers syndrome associated with the A467T substitution in POLG, a patient with dGK mutations, and a patient with mtDNA depletion of unknown origin compared to controls. However, incorporation of alpha (32)P-dTTP relative to either cell doubling time or alpha (32)P-dCTP incorporation was increased in patients with thymidine kinase deficiency or PEO as the result of TWINKLE mutations compared with controls. The specific activity of newly synthesized mtDNA depends on the size of the endogenous pool diluting the exogenous labelled nucleotide. Our result is consistent with a deficiency in the intramitochondrial pool of dTTP relative to dCTP in cells from patients with TK2 deficiency and TWINKLE mutations. Such DNA precursor asymmetry could cause pausing of the replication complex and hence exacerbate the propensity for age-related mtDNA mutations. Because deviations from the normal concentrations of dNTPs are known to be mutagenic, we suggest that intramitochondrial nucleotide imbalance could underlie the multiple mtDNA mutations observed in these patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17483096     DOI: 10.1093/hmg/ddm090

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  17 in total

1.  OPA1 links human mitochondrial genome maintenance to mtDNA replication and distribution.

Authors:  Ghizlane Elachouri; Sara Vidoni; Claudia Zanna; Alexandre Pattyn; Hassan Boukhaddaoui; Karen Gaget; Patrick Yu-Wai-Man; Giuseppe Gasparre; Emmanuelle Sarzi; Cécile Delettre; Aurélien Olichon; Dominique Loiseau; Pascal Reynier; Patrick F Chinnery; Agnès Rotig; Valerio Carelli; Christian P Hamel; Michela Rugolo; Guy Lenaers
Journal:  Genome Res       Date:  2010-10-25       Impact factor: 9.043

Review 2.  The importance of mitochondria in age-related and inherited eye disorders.

Authors:  Stuart G Jarrett; Alfred S Lewin; Michael E Boulton
Journal:  Ophthalmic Res       Date:  2010-09-09       Impact factor: 2.892

3.  Encephalomyopathies caused by abnormal nuclear-mitochondrial intergenomic cross-talk.

Authors:  C Lamperti; M Zeviani
Journal:  Acta Myol       Date:  2009-07

4.  Differential regulation of full-length genome and a single-stranded 7S DNA along the cell cycle in human mitochondria.

Authors:  Anita Antes; Inger Tappin; Stella Chung; Robert Lim; Bin Lu; Andrew M Parrott; Helene Z Hill; Carolyn K Suzuki; Chee-Gun Lee
Journal:  Nucleic Acids Res       Date:  2010-06-08       Impact factor: 16.971

Review 5.  Human mitochondrial DNA: roles of inherited and somatic mutations.

Authors:  Eric A Schon; Salvatore DiMauro; Michio Hirano
Journal:  Nat Rev Genet       Date:  2012-12       Impact factor: 53.242

6.  Effects of zidovudine and stavudine on mitochondrial DNA of differentiating 3T3-F442a cells are not associated with imbalanced deoxynucleotide pools.

Authors:  Matthew D Lynx; Darcy D LaClair; Edward E McKee
Journal:  Antimicrob Agents Chemother       Date:  2008-12-22       Impact factor: 5.191

7.  Clinical and molecular features of mitochondrial DNA depletion syndromes.

Authors:  A Spinazzola; F Invernizzi; F Carrara; E Lamantea; A Donati; M Dirocco; I Giordano; M Meznaric-Petrusa; E Baruffini; I Ferrero; M Zeviani
Journal:  J Inherit Metab Dis       Date:  2008-12-27       Impact factor: 4.982

8.  Effects of Zidovudine Treatment on Heart mRNA Expression and Mitochondrial DNA Copy Number Associated with Alterations in Deoxynucleoside Triphosphate Composition in a Neonatal Rat Model.

Authors:  Jacob W Snowdin; Chia-Heng Hsiung; Daniel G Kesterson; Vasudeva G Kamath; Edward E McKee
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

9.  Ribonucleotide reductase is not limiting for mitochondrial DNA copy number in mice.

Authors:  Emil Ylikallio; Jennifer L Page; Xia Xu; Milla Lampinen; Gerold Bepler; Tomomi Ide; Henna Tyynismaa; Robert S Weiss; Anu Suomalainen
Journal:  Nucleic Acids Res       Date:  2010-08-19       Impact factor: 16.971

10.  In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion.

Authors:  Stefanie Bulst; Elke Holinski-Feder; Brendan Payne; Angela Abicht; Sabine Krause; Hanns Lochmüller; Patrick F Chinnery; Maggie C Walter; Rita Horvath
Journal:  Mol Genet Metab       Date:  2012-05-03       Impact factor: 4.797

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.